Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.02 USD | -3.93% | -6.96% | -26.64% |
May. 20 | Chinese Regulator Approves Zai Lab’s New Drug Application for Bacterial Pneumonia Drug | MT |
May. 20 | Zai Lab, Innoviva Subsidiary Receive China Approval for Hospital Infection Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.64% | 2.07B | |
-3.15% | 89.69B | |
+2.50% | 41.34B | |
-12.10% | 33.72B | |
+62.74% | 26.11B | |
-20.24% | 14.63B | |
-8.57% | 12.84B | |
-12.34% | 11.66B | |
-43.92% | 11.52B | |
+4.27% | 8.92B |
- Stock Market
- Equities
- ZLAB Stock
- News Zai Lab Limited
- Transcript : Zai Lab Limited Presents at Citi’s 16th Annual BioPharma Virtual Conference, Sep-10-2021 11